NovoCure (NVCR) Shares Outstanding (2014 - 2026)

NovoCure's Shares Outstanding history runs 13 years deep, the most recent figure standing at $115.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 3.89% year-over-year to $115.8 million; the TTM figure through Mar 2026 stood at $115.8 million (up 3.89% YoY), while the FY2025 annual figure was $112.5 million, up 3.66% from the prior year.
• Shares Outstanding came in at $115.8 million for Q1 2026 at NovoCure, up from $112.5 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $115.8 million in Q1 2026 to a low of $104.6 million in Q1 2022.
• A 5-year average of $108.3 million and a median of $107.6 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding gained 1.04% in 2022 and gained 3.89% in 2026, its largest moves.
• NovoCure's Shares Outstanding stood at $105.0 million in 2022, then gained by 1.93% to $107.1 million in 2023, then advanced by 1.35% to $108.5 million in 2024, then increased by 3.66% to $112.5 million in 2025, then climbed by 2.96% to $115.8 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $115.8 million, $112.5 million, and $112.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison